注射用フォサプレピタントジメグルミンの世界市場成長2024-2030年Global Fosaprepitant Dimeglumine for Injection Market Growth 2024-2030 フォサプレピタントジメグルミンは、アプレピタントのホスホン酸プロドラッグであり、体内で速やかに加水分解を受けてアプレピタントに代謝される。主に催吐性の高い抗がん化学療法中に起こる悪心・嘔吐の治療に... もっと見る
日本語のページは自動翻訳を利用し作成しています。
サマリーフォサプレピタントジメグルミンは、アプレピタントのホスホン酸プロドラッグであり、体内で速やかに加水分解を受けてアプレピタントに代謝される。主に催吐性の高い抗がん化学療法中に起こる悪心・嘔吐の治療に使用される。注射用フォスアプレピタント・ジメグルミンの世界市場規模は、2024年の100万米ドルから2030年には100万米ドルに成長すると予測されており、2024年から2030年までの年平均成長率は%であると予測されています。 LPインフォメーション株式会社(東京都千代田区/代表取締役:劉克振、以下LPI)の最新リサーチレポート「注射用フォスアプレピタントジメグルミン(Fosaprepitant Dimeglumine for Injection)産業予測」は、2023年の注射用フォスアプレピタントジメグルミン(Fosaprepitant Dimeglumine for Injection)の世界総売上高を調査し、2024年から2030年に予測される注射用フォスアプレピタントジメグルミン(Fosaprepitant Dimeglumine for Injection)の売上高を地域別・市場分野別に包括的に分析しています。この調査レポートは、注射用フォスアプレピタントジメグルミンの売上高を地域別、市場分野別、サブセクター別に分類し、世界の注射用フォスアプレピタントジメグルミン産業の詳細な分析を掲載しています(単位:百万米ドル)。 この調査レポートは、世界の注射用フォスアプレピタントジメグルミンを包括的に分析し、製品セグメンテーション、企業形成、収益、市場シェア、最新動向、M&A活動に関する主要動向を明らかにします。また本レポートでは、注射用フォスアプレピタントジメグルミンのポートフォリオと能力、市場参入戦略、市場での地位、地理的な足跡に焦点を当てて、主要グローバル企業の戦略を分析し、加速する世界の注射用フォスアプレピタントジメグルミン市場におけるこれらの企業の独自の地位をより良く理解しています。 この調査レポートは、注射用フォスアプレピタントジメグルミンの世界的な見通しを形成する主要な市場動向、促進要因、影響要因を評価し、タイプ別、用途別、地域別、市場規模別の予測に分類して、新たな機会のポケットを浮き彫りにします。何百ものボトムアップの定性的・定量的市場インプットに基づいた透明性の高い手法により、この調査予測は世界の注射用フォスアプレピタントジメグルミンの現状と将来の軌道について非常にニュアンスのある見解を提供します。 注射用フォスアプレピタント・ジメグルミンの米国市場は、2023年の100万米ドルから2030年には100万米ドルに増加し、2024年から2030年までの年平均成長率は%と推定される。 注射用フォスアプレピタントジメグルミンの中国市場は、2023年の百万米ドルから2030年には百万米ドルに増加し、2024年から2030年までの年平均成長率は%と推定される。 注射用フォスアプレピタントジメグルミンのヨーロッパ市場は、2023年の百万米ドルから2030年には百万米ドルに増加し、2024年から2030年までの年平均成長率は%と推定される。 注射用フォスアプレピタントジメグルミンの世界的な主要プレイヤーは、Merck & Co、SPES PHARMACEUTICALS、Sungen Pharma、Hansoh Pharmaceutical、CTTQなどである。売上高では、世界の2大企業が2023年にほぼ%のシェアを占めている。 のシェアを占めている。 この調査レポートは、注射用フォスアプレピタントジメグルミン市場の製品タイプ、用途、主要メーカー、主要地域、国別の包括的な概要、市場シェア、成長機会を掲載しています。 タイプ別セグメント 先発医薬品 ジェネリック医薬品 用途別セグメント 病院 クリニック その他 本レポートはまた、市場を地域別に分けています: 南北アメリカ アメリカ カナダ メキシコ ブラジル APAC 中国 日本 韓国 東南アジア インド オーストラリア ヨーロッパ ドイツ フランス 英国 イタリア ロシア 中東・アフリカ エジプト 南アフリカ イスラエル トルコ GCC諸国 以下の企業は、一次専門家から収集した情報、および企業のカバレッジ、製品ポートフォリオ、市場浸透度の分析に基づいて選択されています。 メルク・アンド・カンパニー スペスファーマ サンゲンファーマ ハンソー製薬 CTTQ 斉魯製薬 洛新製薬 蒼彩康医薬 九元遺伝子工学 西濃生物製薬 セーロン製薬 本レポートで扱う主な質問 世界の注射用フォサプレピタントジメグルミン市場の10年見通しは? 注射用フォスアプレピタントジメグルミン市場の成長を促進する世界および地域別の要因は何か? 市場別、地域別で最も急成長する技術は何か? 注射用フォスアプレピタントジメグルミン市場の機会は最終市場規模によってどのように異なるのか? 注射用フォスアプレピタントジメグルミンのタイプ別、用途別の内訳は? 目次1 Scope of the Report1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 1.8 Market Estimation Caveats 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Fosaprepitant Dimeglumine for Injection Annual Sales 2019-2030 2.1.2 World Current & Future Analysis for Fosaprepitant Dimeglumine for Injection by Geographic Region, 2019, 2023 & 2030 2.1.3 World Current & Future Analysis for Fosaprepitant Dimeglumine for Injection by Country/Region, 2019, 2023 & 2030 2.2 Fosaprepitant Dimeglumine for Injection Segment by Type 2.2.1 Original Drug 2.2.2 Generic Drug 2.3 Fosaprepitant Dimeglumine for Injection Sales by Type 2.3.1 Global Fosaprepitant Dimeglumine for Injection Sales Market Share by Type (2019-2024) 2.3.2 Global Fosaprepitant Dimeglumine for Injection Revenue and Market Share by Type (2019-2024) 2.3.3 Global Fosaprepitant Dimeglumine for Injection Sale Price by Type (2019-2024) 2.4 Fosaprepitant Dimeglumine for Injection Segment by Application 2.4.1 Hospital 2.4.2 Clinic 2.4.3 Others 2.5 Fosaprepitant Dimeglumine for Injection Sales by Application 2.5.1 Global Fosaprepitant Dimeglumine for Injection Sale Market Share by Application (2019-2024) 2.5.2 Global Fosaprepitant Dimeglumine for Injection Revenue and Market Share by Application (2019-2024) 2.5.3 Global Fosaprepitant Dimeglumine for Injection Sale Price by Application (2019-2024) 3 Global by Company 3.1 Global Fosaprepitant Dimeglumine for Injection Breakdown Data by Company 3.1.1 Global Fosaprepitant Dimeglumine for Injection Annual Sales by Company (2019-2024) 3.1.2 Global Fosaprepitant Dimeglumine for Injection Sales Market Share by Company (2019-2024) 3.2 Global Fosaprepitant Dimeglumine for Injection Annual Revenue by Company (2019-2024) 3.2.1 Global Fosaprepitant Dimeglumine for Injection Revenue by Company (2019-2024) 3.2.2 Global Fosaprepitant Dimeglumine for Injection Revenue Market Share by Company (2019-2024) 3.3 Global Fosaprepitant Dimeglumine for Injection Sale Price by Company 3.4 Key Manufacturers Fosaprepitant Dimeglumine for Injection Producing Area Distribution, Sales Area, Product Type 3.4.1 Key Manufacturers Fosaprepitant Dimeglumine for Injection Product Location Distribution 3.4.2 Players Fosaprepitant Dimeglumine for Injection Products Offered 3.5 Market Concentration Rate Analysis 3.5.1 Competition Landscape Analysis 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024) 3.6 New Products and Potential Entrants 3.7 Market M&A Activity & Strategy 4 World Historic Review for Fosaprepitant Dimeglumine for Injection by Geographic Region 4.1 World Historic Fosaprepitant Dimeglumine for Injection Market Size by Geographic Region (2019-2024) 4.1.1 Global Fosaprepitant Dimeglumine for Injection Annual Sales by Geographic Region (2019-2024) 4.1.2 Global Fosaprepitant Dimeglumine for Injection Annual Revenue by Geographic Region (2019-2024) 4.2 World Historic Fosaprepitant Dimeglumine for Injection Market Size by Country/Region (2019-2024) 4.2.1 Global Fosaprepitant Dimeglumine for Injection Annual Sales by Country/Region (2019-2024) 4.2.2 Global Fosaprepitant Dimeglumine for Injection Annual Revenue by Country/Region (2019-2024) 4.3 Americas Fosaprepitant Dimeglumine for Injection Sales Growth 4.4 APAC Fosaprepitant Dimeglumine for Injection Sales Growth 4.5 Europe Fosaprepitant Dimeglumine for Injection Sales Growth 4.6 Middle East & Africa Fosaprepitant Dimeglumine for Injection Sales Growth 5 Americas 5.1 Americas Fosaprepitant Dimeglumine for Injection Sales by Country 5.1.1 Americas Fosaprepitant Dimeglumine for Injection Sales by Country (2019-2024) 5.1.2 Americas Fosaprepitant Dimeglumine for Injection Revenue by Country (2019-2024) 5.2 Americas Fosaprepitant Dimeglumine for Injection Sales by Type (2019-2024) 5.3 Americas Fosaprepitant Dimeglumine for Injection Sales by Application (2019-2024) 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Fosaprepitant Dimeglumine for Injection Sales by Region 6.1.1 APAC Fosaprepitant Dimeglumine for Injection Sales by Region (2019-2024) 6.1.2 APAC Fosaprepitant Dimeglumine for Injection Revenue by Region (2019-2024) 6.2 APAC Fosaprepitant Dimeglumine for Injection Sales by Type (2019-2024) 6.3 APAC Fosaprepitant Dimeglumine for Injection Sales by Application (2019-2024) 6.4 China 6.5 Japan 6.6 South Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 6.10 China Taiwan 7 Europe 7.1 Europe Fosaprepitant Dimeglumine for Injection by Country 7.1.1 Europe Fosaprepitant Dimeglumine for Injection Sales by Country (2019-2024) 7.1.2 Europe Fosaprepitant Dimeglumine for Injection Revenue by Country (2019-2024) 7.2 Europe Fosaprepitant Dimeglumine for Injection Sales by Type (2019-2024) 7.3 Europe Fosaprepitant Dimeglumine for Injection Sales by Application (2019-2024) 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Fosaprepitant Dimeglumine for Injection by Country 8.1.1 Middle East & Africa Fosaprepitant Dimeglumine for Injection Sales by Country (2019-2024) 8.1.2 Middle East & Africa Fosaprepitant Dimeglumine for Injection Revenue by Country (2019-2024) 8.2 Middle East & Africa Fosaprepitant Dimeglumine for Injection Sales by Type (2019-2024) 8.3 Middle East & Africa Fosaprepitant Dimeglumine for Injection Sales by Application (2019-2024) 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Manufacturing Cost Structure Analysis 10.1 Raw Material and Suppliers 10.2 Manufacturing Cost Structure Analysis of Fosaprepitant Dimeglumine for Injection 10.3 Manufacturing Process Analysis of Fosaprepitant Dimeglumine for Injection 10.4 Industry Chain Structure of Fosaprepitant Dimeglumine for Injection 11 Marketing, Distributors and Customer 11.1 Sales Channel 11.1.1 Direct Channels 11.1.2 Indirect Channels 11.2 Fosaprepitant Dimeglumine for Injection Distributors 11.3 Fosaprepitant Dimeglumine for Injection Customer 12 World Forecast Review for Fosaprepitant Dimeglumine for Injection by Geographic Region 12.1 Global Fosaprepitant Dimeglumine for Injection Market Size Forecast by Region 12.1.1 Global Fosaprepitant Dimeglumine for Injection Forecast by Region (2025-2030) 12.1.2 Global Fosaprepitant Dimeglumine for Injection Annual Revenue Forecast by Region (2025-2030) 12.2 Americas Forecast by Country (2025-2030) 12.3 APAC Forecast by Region (2025-2030) 12.4 Europe Forecast by Country (2025-2030) 12.5 Middle East & Africa Forecast by Country (2025-2030) 12.6 Global Fosaprepitant Dimeglumine for Injection Forecast by Type (2025-2030) 12.7 Global Fosaprepitant Dimeglumine for Injection Forecast by Application (2025-2030) 13 Key Players Analysis 13.1 Merck & Co 13.1.1 Merck & Co Company Information 13.1.2 Merck & Co Fosaprepitant Dimeglumine for Injection Product Portfolios and Specifications 13.1.3 Merck & Co Fosaprepitant Dimeglumine for Injection Sales, Revenue, Price and Gross Margin (2019-2024) 13.1.4 Merck & Co Main Business Overview 13.1.5 Merck & Co Latest Developments 13.2 SPES PHARMACEUTICALS 13.2.1 SPES PHARMACEUTICALS Company Information 13.2.2 SPES PHARMACEUTICALS Fosaprepitant Dimeglumine for Injection Product Portfolios and Specifications 13.2.3 SPES PHARMACEUTICALS Fosaprepitant Dimeglumine for Injection Sales, Revenue, Price and Gross Margin (2019-2024) 13.2.4 SPES PHARMACEUTICALS Main Business Overview 13.2.5 SPES PHARMACEUTICALS Latest Developments 13.3 Sungen Pharma 13.3.1 Sungen Pharma Company Information 13.3.2 Sungen Pharma Fosaprepitant Dimeglumine for Injection Product Portfolios and Specifications 13.3.3 Sungen Pharma Fosaprepitant Dimeglumine for Injection Sales, Revenue, Price and Gross Margin (2019-2024) 13.3.4 Sungen Pharma Main Business Overview 13.3.5 Sungen Pharma Latest Developments 13.4 Hansoh Pharmaceutical 13.4.1 Hansoh Pharmaceutical Company Information 13.4.2 Hansoh Pharmaceutical Fosaprepitant Dimeglumine for Injection Product Portfolios and Specifications 13.4.3 Hansoh Pharmaceutical Fosaprepitant Dimeglumine for Injection Sales, Revenue, Price and Gross Margin (2019-2024) 13.4.4 Hansoh Pharmaceutical Main Business Overview 13.4.5 Hansoh Pharmaceutical Latest Developments 13.5 CTTQ 13.5.1 CTTQ Company Information 13.5.2 CTTQ Fosaprepitant Dimeglumine for Injection Product Portfolios and Specifications 13.5.3 CTTQ Fosaprepitant Dimeglumine for Injection Sales, Revenue, Price and Gross Margin (2019-2024) 13.5.4 CTTQ Main Business Overview 13.5.5 CTTQ Latest Developments 13.6 Qilu Pharmaceutical 13.6.1 Qilu Pharmaceutical Company Information 13.6.2 Qilu Pharmaceutical Fosaprepitant Dimeglumine for Injection Product Portfolios and Specifications 13.6.3 Qilu Pharmaceutical Fosaprepitant Dimeglumine for Injection Sales, Revenue, Price and Gross Margin (2019-2024) 13.6.4 Qilu Pharmaceutical Main Business Overview 13.6.5 Qilu Pharmaceutical Latest Developments 13.7 Luoxin Pharmaceuticals 13.7.1 Luoxin Pharmaceuticals Company Information 13.7.2 Luoxin Pharmaceuticals Fosaprepitant Dimeglumine for Injection Product Portfolios and Specifications 13.7.3 Luoxin Pharmaceuticals Fosaprepitant Dimeglumine for Injection Sales, Revenue, Price and Gross Margin (2019-2024) 13.7.4 Luoxin Pharmaceuticals Main Business Overview 13.7.5 Luoxin Pharmaceuticals Latest Developments 13.8 Aosaikang Pharmaceutical 13.8.1 Aosaikang Pharmaceutical Company Information 13.8.2 Aosaikang Pharmaceutical Fosaprepitant Dimeglumine for Injection Product Portfolios and Specifications 13.8.3 Aosaikang Pharmaceutical Fosaprepitant Dimeglumine for Injection Sales, Revenue, Price and Gross Margin (2019-2024) 13.8.4 Aosaikang Pharmaceutical Main Business Overview 13.8.5 Aosaikang Pharmaceutical Latest Developments 13.9 jiuyuan gene engineering 13.9.1 jiuyuan gene engineering Company Information 13.9.2 jiuyuan gene engineering Fosaprepitant Dimeglumine for Injection Product Portfolios and Specifications 13.9.3 jiuyuan gene engineering Fosaprepitant Dimeglumine for Injection Sales, Revenue, Price and Gross Margin (2019-2024) 13.9.4 jiuyuan gene engineering Main Business Overview 13.9.5 jiuyuan gene engineering Latest Developments 13.10 Sino Biopharmaceutical 13.10.1 Sino Biopharmaceutical Company Information 13.10.2 Sino Biopharmaceutical Fosaprepitant Dimeglumine for Injection Product Portfolios and Specifications 13.10.3 Sino Biopharmaceutical Fosaprepitant Dimeglumine for Injection Sales, Revenue, Price and Gross Margin (2019-2024) 13.10.4 Sino Biopharmaceutical Main Business Overview 13.10.5 Sino Biopharmaceutical Latest Developments 13.11 Sailong Pharmaceutical 13.11.1 Sailong Pharmaceutical Company Information 13.11.2 Sailong Pharmaceutical Fosaprepitant Dimeglumine for Injection Product Portfolios and Specifications 13.11.3 Sailong Pharmaceutical Fosaprepitant Dimeglumine for Injection Sales, Revenue, Price and Gross Margin (2019-2024) 13.11.4 Sailong Pharmaceutical Main Business Overview 13.11.5 Sailong Pharmaceutical Latest Developments 14 Research Findings and Conclusion
SummaryFosaprepitant dimeglumine is the phosphonate prodrug of aprepitant, which rapidly undergoes hydrolysis in the body to metabolize into aprepitant. It is primarily used to treat nausea and vomiting that occur during highly emetogenic anticancer chemotherapy. Table of Contents1 Scope of the Report1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 1.8 Market Estimation Caveats 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Fosaprepitant Dimeglumine for Injection Annual Sales 2019-2030 2.1.2 World Current & Future Analysis for Fosaprepitant Dimeglumine for Injection by Geographic Region, 2019, 2023 & 2030 2.1.3 World Current & Future Analysis for Fosaprepitant Dimeglumine for Injection by Country/Region, 2019, 2023 & 2030 2.2 Fosaprepitant Dimeglumine for Injection Segment by Type 2.2.1 Original Drug 2.2.2 Generic Drug 2.3 Fosaprepitant Dimeglumine for Injection Sales by Type 2.3.1 Global Fosaprepitant Dimeglumine for Injection Sales Market Share by Type (2019-2024) 2.3.2 Global Fosaprepitant Dimeglumine for Injection Revenue and Market Share by Type (2019-2024) 2.3.3 Global Fosaprepitant Dimeglumine for Injection Sale Price by Type (2019-2024) 2.4 Fosaprepitant Dimeglumine for Injection Segment by Application 2.4.1 Hospital 2.4.2 Clinic 2.4.3 Others 2.5 Fosaprepitant Dimeglumine for Injection Sales by Application 2.5.1 Global Fosaprepitant Dimeglumine for Injection Sale Market Share by Application (2019-2024) 2.5.2 Global Fosaprepitant Dimeglumine for Injection Revenue and Market Share by Application (2019-2024) 2.5.3 Global Fosaprepitant Dimeglumine for Injection Sale Price by Application (2019-2024) 3 Global by Company 3.1 Global Fosaprepitant Dimeglumine for Injection Breakdown Data by Company 3.1.1 Global Fosaprepitant Dimeglumine for Injection Annual Sales by Company (2019-2024) 3.1.2 Global Fosaprepitant Dimeglumine for Injection Sales Market Share by Company (2019-2024) 3.2 Global Fosaprepitant Dimeglumine for Injection Annual Revenue by Company (2019-2024) 3.2.1 Global Fosaprepitant Dimeglumine for Injection Revenue by Company (2019-2024) 3.2.2 Global Fosaprepitant Dimeglumine for Injection Revenue Market Share by Company (2019-2024) 3.3 Global Fosaprepitant Dimeglumine for Injection Sale Price by Company 3.4 Key Manufacturers Fosaprepitant Dimeglumine for Injection Producing Area Distribution, Sales Area, Product Type 3.4.1 Key Manufacturers Fosaprepitant Dimeglumine for Injection Product Location Distribution 3.4.2 Players Fosaprepitant Dimeglumine for Injection Products Offered 3.5 Market Concentration Rate Analysis 3.5.1 Competition Landscape Analysis 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024) 3.6 New Products and Potential Entrants 3.7 Market M&A Activity & Strategy 4 World Historic Review for Fosaprepitant Dimeglumine for Injection by Geographic Region 4.1 World Historic Fosaprepitant Dimeglumine for Injection Market Size by Geographic Region (2019-2024) 4.1.1 Global Fosaprepitant Dimeglumine for Injection Annual Sales by Geographic Region (2019-2024) 4.1.2 Global Fosaprepitant Dimeglumine for Injection Annual Revenue by Geographic Region (2019-2024) 4.2 World Historic Fosaprepitant Dimeglumine for Injection Market Size by Country/Region (2019-2024) 4.2.1 Global Fosaprepitant Dimeglumine for Injection Annual Sales by Country/Region (2019-2024) 4.2.2 Global Fosaprepitant Dimeglumine for Injection Annual Revenue by Country/Region (2019-2024) 4.3 Americas Fosaprepitant Dimeglumine for Injection Sales Growth 4.4 APAC Fosaprepitant Dimeglumine for Injection Sales Growth 4.5 Europe Fosaprepitant Dimeglumine for Injection Sales Growth 4.6 Middle East & Africa Fosaprepitant Dimeglumine for Injection Sales Growth 5 Americas 5.1 Americas Fosaprepitant Dimeglumine for Injection Sales by Country 5.1.1 Americas Fosaprepitant Dimeglumine for Injection Sales by Country (2019-2024) 5.1.2 Americas Fosaprepitant Dimeglumine for Injection Revenue by Country (2019-2024) 5.2 Americas Fosaprepitant Dimeglumine for Injection Sales by Type (2019-2024) 5.3 Americas Fosaprepitant Dimeglumine for Injection Sales by Application (2019-2024) 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Fosaprepitant Dimeglumine for Injection Sales by Region 6.1.1 APAC Fosaprepitant Dimeglumine for Injection Sales by Region (2019-2024) 6.1.2 APAC Fosaprepitant Dimeglumine for Injection Revenue by Region (2019-2024) 6.2 APAC Fosaprepitant Dimeglumine for Injection Sales by Type (2019-2024) 6.3 APAC Fosaprepitant Dimeglumine for Injection Sales by Application (2019-2024) 6.4 China 6.5 Japan 6.6 South Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 6.10 China Taiwan 7 Europe 7.1 Europe Fosaprepitant Dimeglumine for Injection by Country 7.1.1 Europe Fosaprepitant Dimeglumine for Injection Sales by Country (2019-2024) 7.1.2 Europe Fosaprepitant Dimeglumine for Injection Revenue by Country (2019-2024) 7.2 Europe Fosaprepitant Dimeglumine for Injection Sales by Type (2019-2024) 7.3 Europe Fosaprepitant Dimeglumine for Injection Sales by Application (2019-2024) 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Fosaprepitant Dimeglumine for Injection by Country 8.1.1 Middle East & Africa Fosaprepitant Dimeglumine for Injection Sales by Country (2019-2024) 8.1.2 Middle East & Africa Fosaprepitant Dimeglumine for Injection Revenue by Country (2019-2024) 8.2 Middle East & Africa Fosaprepitant Dimeglumine for Injection Sales by Type (2019-2024) 8.3 Middle East & Africa Fosaprepitant Dimeglumine for Injection Sales by Application (2019-2024) 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Manufacturing Cost Structure Analysis 10.1 Raw Material and Suppliers 10.2 Manufacturing Cost Structure Analysis of Fosaprepitant Dimeglumine for Injection 10.3 Manufacturing Process Analysis of Fosaprepitant Dimeglumine for Injection 10.4 Industry Chain Structure of Fosaprepitant Dimeglumine for Injection 11 Marketing, Distributors and Customer 11.1 Sales Channel 11.1.1 Direct Channels 11.1.2 Indirect Channels 11.2 Fosaprepitant Dimeglumine for Injection Distributors 11.3 Fosaprepitant Dimeglumine for Injection Customer 12 World Forecast Review for Fosaprepitant Dimeglumine for Injection by Geographic Region 12.1 Global Fosaprepitant Dimeglumine for Injection Market Size Forecast by Region 12.1.1 Global Fosaprepitant Dimeglumine for Injection Forecast by Region (2025-2030) 12.1.2 Global Fosaprepitant Dimeglumine for Injection Annual Revenue Forecast by Region (2025-2030) 12.2 Americas Forecast by Country (2025-2030) 12.3 APAC Forecast by Region (2025-2030) 12.4 Europe Forecast by Country (2025-2030) 12.5 Middle East & Africa Forecast by Country (2025-2030) 12.6 Global Fosaprepitant Dimeglumine for Injection Forecast by Type (2025-2030) 12.7 Global Fosaprepitant Dimeglumine for Injection Forecast by Application (2025-2030) 13 Key Players Analysis 13.1 Merck & Co 13.1.1 Merck & Co Company Information 13.1.2 Merck & Co Fosaprepitant Dimeglumine for Injection Product Portfolios and Specifications 13.1.3 Merck & Co Fosaprepitant Dimeglumine for Injection Sales, Revenue, Price and Gross Margin (2019-2024) 13.1.4 Merck & Co Main Business Overview 13.1.5 Merck & Co Latest Developments 13.2 SPES PHARMACEUTICALS 13.2.1 SPES PHARMACEUTICALS Company Information 13.2.2 SPES PHARMACEUTICALS Fosaprepitant Dimeglumine for Injection Product Portfolios and Specifications 13.2.3 SPES PHARMACEUTICALS Fosaprepitant Dimeglumine for Injection Sales, Revenue, Price and Gross Margin (2019-2024) 13.2.4 SPES PHARMACEUTICALS Main Business Overview 13.2.5 SPES PHARMACEUTICALS Latest Developments 13.3 Sungen Pharma 13.3.1 Sungen Pharma Company Information 13.3.2 Sungen Pharma Fosaprepitant Dimeglumine for Injection Product Portfolios and Specifications 13.3.3 Sungen Pharma Fosaprepitant Dimeglumine for Injection Sales, Revenue, Price and Gross Margin (2019-2024) 13.3.4 Sungen Pharma Main Business Overview 13.3.5 Sungen Pharma Latest Developments 13.4 Hansoh Pharmaceutical 13.4.1 Hansoh Pharmaceutical Company Information 13.4.2 Hansoh Pharmaceutical Fosaprepitant Dimeglumine for Injection Product Portfolios and Specifications 13.4.3 Hansoh Pharmaceutical Fosaprepitant Dimeglumine for Injection Sales, Revenue, Price and Gross Margin (2019-2024) 13.4.4 Hansoh Pharmaceutical Main Business Overview 13.4.5 Hansoh Pharmaceutical Latest Developments 13.5 CTTQ 13.5.1 CTTQ Company Information 13.5.2 CTTQ Fosaprepitant Dimeglumine for Injection Product Portfolios and Specifications 13.5.3 CTTQ Fosaprepitant Dimeglumine for Injection Sales, Revenue, Price and Gross Margin (2019-2024) 13.5.4 CTTQ Main Business Overview 13.5.5 CTTQ Latest Developments 13.6 Qilu Pharmaceutical 13.6.1 Qilu Pharmaceutical Company Information 13.6.2 Qilu Pharmaceutical Fosaprepitant Dimeglumine for Injection Product Portfolios and Specifications 13.6.3 Qilu Pharmaceutical Fosaprepitant Dimeglumine for Injection Sales, Revenue, Price and Gross Margin (2019-2024) 13.6.4 Qilu Pharmaceutical Main Business Overview 13.6.5 Qilu Pharmaceutical Latest Developments 13.7 Luoxin Pharmaceuticals 13.7.1 Luoxin Pharmaceuticals Company Information 13.7.2 Luoxin Pharmaceuticals Fosaprepitant Dimeglumine for Injection Product Portfolios and Specifications 13.7.3 Luoxin Pharmaceuticals Fosaprepitant Dimeglumine for Injection Sales, Revenue, Price and Gross Margin (2019-2024) 13.7.4 Luoxin Pharmaceuticals Main Business Overview 13.7.5 Luoxin Pharmaceuticals Latest Developments 13.8 Aosaikang Pharmaceutical 13.8.1 Aosaikang Pharmaceutical Company Information 13.8.2 Aosaikang Pharmaceutical Fosaprepitant Dimeglumine for Injection Product Portfolios and Specifications 13.8.3 Aosaikang Pharmaceutical Fosaprepitant Dimeglumine for Injection Sales, Revenue, Price and Gross Margin (2019-2024) 13.8.4 Aosaikang Pharmaceutical Main Business Overview 13.8.5 Aosaikang Pharmaceutical Latest Developments 13.9 jiuyuan gene engineering 13.9.1 jiuyuan gene engineering Company Information 13.9.2 jiuyuan gene engineering Fosaprepitant Dimeglumine for Injection Product Portfolios and Specifications 13.9.3 jiuyuan gene engineering Fosaprepitant Dimeglumine for Injection Sales, Revenue, Price and Gross Margin (2019-2024) 13.9.4 jiuyuan gene engineering Main Business Overview 13.9.5 jiuyuan gene engineering Latest Developments 13.10 Sino Biopharmaceutical 13.10.1 Sino Biopharmaceutical Company Information 13.10.2 Sino Biopharmaceutical Fosaprepitant Dimeglumine for Injection Product Portfolios and Specifications 13.10.3 Sino Biopharmaceutical Fosaprepitant Dimeglumine for Injection Sales, Revenue, Price and Gross Margin (2019-2024) 13.10.4 Sino Biopharmaceutical Main Business Overview 13.10.5 Sino Biopharmaceutical Latest Developments 13.11 Sailong Pharmaceutical 13.11.1 Sailong Pharmaceutical Company Information 13.11.2 Sailong Pharmaceutical Fosaprepitant Dimeglumine for Injection Product Portfolios and Specifications 13.11.3 Sailong Pharmaceutical Fosaprepitant Dimeglumine for Injection Sales, Revenue, Price and Gross Margin (2019-2024) 13.11.4 Sailong Pharmaceutical Main Business Overview 13.11.5 Sailong Pharmaceutical Latest Developments 14 Research Findings and Conclusion
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(医薬)の最新刊レポート
LP Information社の医薬品・ヘルスケア分野での最新刊レポート本レポートと同じKEY WORD(injection)の最新刊レポート
よくあるご質問LP Information社はどのような調査会社ですか?LP Informationは通信、エネルギー、医薬をはじめとする広範な市場の調査とレポート出版を行っている調査会社です。 もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/11/22 10:26 155.52 円 163.34 円 198.56 円 |